Emelina Stambolliu | AI in Healthcare | Excellence in Research Award

Published on by AI Data Scientist

Dr. Emelina Stambolliu | AI in Healthcare | Excellence in Research Award

Supervising physician | Hippokration General Hopsital of Athens,Greece | Greece

Dr. Emelina Stambolliu is a clinician-researcher at Hippokration General Hospital of Athens whose work focuses on hypertension, kidney disease, and cardiovascular risk, with growing integration of AI-driven analysis in healthcare. Her research emphasizes advanced blood pressure monitoring (office, home, ambulatory), early detection of target-organ damage, and cardiorenal interactions across pediatric and adult populations. She has contributed extensively to evidence-based clinical decision support, systematic reviews, and validation of medical monitoring devices, supporting precision medicine and data-informed patient care


View Orcid Profile

Featured Publications

Eva Godina | Medicine | Best Researcher Award

Published on by AI Data Scientist

Ms. Eva Godina | Medicine | Best Researcher Award

Medical Student at Maastricht University, Netherlands

Eva Godina is a highly accomplished and internationally active medical student and researcher with a distinctive academic and clinical profile. Currently pursuing a Master of Medicine at Maastricht University in the Netherlands, she combines exceptional academic performance with a strong commitment to advancing research and clinical practices, particularly in oncology and reconstructive surgery. Known for her top-tier achievements, including graduating Cum Laude and receiving the prestigious Dies Natalis Bachelor Award, Eva has consistently demonstrated excellence in both education and research. Her interests span experimental oncology, plastic surgery, and decision support systems for cancer treatment.

Eva’s extensive hands-on experience through clinical electives and observerships at globally renowned institutions such as Harvard Medical School, Stanford, and MD Anderson Cancer Center reflects her dedication to developing her expertise across disciplines and borders. She has co-authored multiple peer-reviewed journal articles, presented at prestigious conferences, and is actively contributing to ongoing clinical and experimental studies. Beyond academics, she is also engaged in mentoring and leadership roles within international organizations, promoting medical education and disease prevention. With a robust foundation in science, communication, and compassion, Eva is poised to become a transformative force in medicine and healthcare innovation.

Profile

ORCID

Education

Eva Godina’s academic journey reflects an outstanding commitment to excellence and a global outlook. She began her medical education at the University of Ljubljana in Slovenia (2018–2019) with an impressive GPA of 8.9 before transferring to Maastricht University’s Faculty of Health, Medicine, and Life Sciences in the Netherlands. There, she completed a Bachelor of Science in Medicine (2019–2022) through the International Track in Medicine, graduating Cum Laude and at the top of her class. Her academic excellence was recognized with the Dies Natalis Bachelor Award, given for outstanding academic results and contributions through her Honours project.

Eva is currently enrolled in the Master of Medicine program at Maastricht University (2023–present), with her graduation expected in August 2025. Prior to university, she attended II. Gymnasium Maribor, Slovenia, graduating in the top 2% internationally with a near-perfect score (44/45). These formative academic experiences laid a strong foundation for her scientific curiosity and global medical perspective. Throughout her education, she has consistently shown the ability to combine rigorous academic pursuits with practical clinical engagement, leadership in extracurricular activities, and meaningful contributions to medical research and community initiatives.

Professional Experience

Eva Godina’s professional medical experience is both rich and international. She has completed high-level clinical internships and observerships in various prestigious institutions, gaining hands-on exposure to plastic and reconstructive surgery, paediatric urology, and oncology. Her recent placements include Harvard Medical School at Massachusetts General Hospital under Dr. Eberlin and Dr. van Mulken (2025–present), as well as Stanford University with Prof. Momeni (2024). She also worked in clinical electives at MUMC+ (Netherlands) and Fundació Puigvert (Spain), specializing in plastic surgery and urology, respectively.

Parallel to her clinical roles, Eva has engaged in diverse research projects. At MD Anderson Cancer Center, she contributed to experimental oncology projects focusing on novel agents for metaplastic breast cancer. At Zuyderland Hospital, she researched Enhanced Recovery After Surgery (ERAS) protocols in colorectal cancer, while at MUMC+, she studied hand-foot syndrome in chemotherapy patients. She also participated in decision-support research for prostate cancer during her Honours program.

In addition to clinical and research work, Eva has contributed to education and communication, serving as a medical illustrator, editor for peer-reviewed journals, and a mentor. These experiences collectively position her as a multi-talented future physician-scientist with a robust international profile.

Research Interest

Eva Godina’s research interests are focused on oncology, particularly breast cancer, reconstructive surgery, and clinical decision-making tools in cancer therapy. Her commitment to translational research that bridges the gap between clinical care and laboratory science is evident in her extensive work with leading cancer institutions and participation in cutting-edge studies. Her projects span experimental and clinical oncology, with a particular interest in metaplastic breast cancer and the use of novel AKT inhibitors, explored during her time at MD Anderson Cancer Center.

Eva also investigates patient-centric outcomes and complications in cancer treatments, such as alpelisib-induced hyperglycemia and hand-foot syndrome, reflecting her interest in precision medicine and improving therapeutic efficacy. Her earlier work involved decision support systems for prostate cancer treatment, demonstrating a strong affinity for digital health tools and AI applications in oncology. These diverse research interests are supported by her participation in research courses by ASCO and AIOM and presentations at leading international conferences such as ASCO and ESMO.

Driven by a desire to enhance clinical protocols and improve patient outcomes, Eva’s research trajectory demonstrates a commitment to innovation, collaborative science, and real-world impact. She envisions a career where she can integrate clinical practice with academic research to advance personalized and evidence-based care.

Research Skills

Eva Godina possesses a broad and well-rounded research skill set, cultivated through academic training, clinical exposure, and active participation in international research collaborations. Her core competencies include clinical research design, data collection and analysis, patient outcome assessments, and manuscript preparation. She is adept at both quantitative and qualitative methodologies, evidenced by her contributions to mixed-method studies, such as the 23-hour enhanced recovery program research published in BMC Health Services Research.

Eva has hands-on experience with oncology trials and observational studies, particularly in breast cancer therapeutics and complications. Her research includes real-world outcome analysis, systematic therapy evaluation, and adverse event correlation—skills she utilized in multiple conference presentations and journal submissions. Furthermore, she is skilled in case study preparation, notably on targeted therapies for metaplastic breast cancer.

Her editorial experience as a peer-reviewed journal editor and illustrator for anatomical diagrams at Maastricht University also highlights her ability to translate complex scientific content into accessible formats. She has also completed specialized clinical research training courses by ASCO and AIOM, further strengthening her theoretical and practical research acumen. These capabilities equip her to navigate interdisciplinary medical research, contributing to both scientific literature and clinical innovation.

Awards and Honors

Eva Godina’s academic and professional journey is decorated with prestigious awards and scholarships recognizing her excellence, talent, and contributions to the field of medicine. Most notably, she received the Dies Natalis Bachelor Award in 2022 for her exceptional study results and Honours research project at Maastricht University, a distinction reserved for top-performing students.

She was also a recipient of the Zois Scholarship, awarded to gifted high school and university students in Slovenia, which she held during both her high school years (2013–2018) and university studies (2023–present). This long-term recognition underscores her consistent academic prowess.

In support of her international education, Eva received the Ad Futura Study Abroad Scholarship from 2020 to 2022, which helped fund her studies in the Netherlands. In 2024, she was awarded a Travel Grant from ASCO to attend a clinical research course, reinforcing her global engagement in cancer research and education.

These awards reflect not only her outstanding academic and research performance but also her proactive involvement in international academic circles. They serve as a testament to her commitment to excellence, innovation, and continuous learning in medical science.

Publications

Eva Godina has an impressive record of scholarly contributions, including peer-reviewed publications, manuscripts under review, and several international conference abstracts and posters. Among her published work, she co-authored a study in BMC Health Services Research (2024) on the implementation of a 23-hour accelerated recovery program, showcasing her interest in health services optimization. She also contributed to an important Annals of Oncology (2020) paper on long-term outcomes with neoadjuvant systemic therapy in breast cancer.

Her work continues with manuscripts currently under review, including a study on prehabilitation programs for colorectal cancer patients submitted to Nutrients, and a case report on a novel AKT inhibitor for metaplastic breast cancer, targeting submission to BJC Reports.

Eva has also presented at internationally renowned conferences. Notably, she was the first author on an abstract presented at ASCO 2023 examining predictors of alpelisib-induced hyperglycemia. She has also presented at the Slovenian Senologic Society’s Oncology Weekend and ESMO 2020.

These publications and presentations affirm her as a rising academic voice in oncology, patient-centered care, and translational medical research, with a strong commitment to contributing to the broader medical and scientific community.

Conclusion

Eva Godina stands out as a promising and multi-talented future physician-scientist whose journey is marked by academic distinction, international clinical experience, and impactful research. Her academic path has been characterized by excellence from the outset, with top-of-the-class honors and awards that recognize both her intellectual capacity and her proactive contributions to science and healthcare.

Through a blend of rigorous education, diverse internships, and in-depth research, Eva has cultivated a multifaceted skill set that positions her at the forefront of modern medicine. Her research in oncology and surgery, particularly with prestigious institutions like MD Anderson and Harvard, is a testament to her global engagement and dedication to advancing medical knowledge.

Moreover, Eva’s involvement in mentoring, leadership, and volunteer initiatives reflects her well-rounded character and deep commitment to service. Her future trajectory promises significant contributions to medical science, especially in areas requiring precision, compassion, and innovation. As she continues her Master’s studies and clinical training, Eva is set to emerge as a leader in both the scientific and clinical communities, exemplifying excellence in every facet of her profession.

Irene Ruengkhachorn | Medicine | Women Researcher Award

Published on by AI Data Scientist

Assoc. Prof. Dr. Irene Ruengkhachorn | Medicine | Women Researcher Award

Associate Professor at Faculty of Meidicine Siriraj Hospital, Mahidol university, Thailand

Dr. Irene Ruengkhachorn is a dedicated academic and clinical specialist in gynecologic oncology, currently serving as an Associate Professor at the Faculty of Medicine Siriraj Hospital, Mahidol University. With nearly two decades of medical and teaching experience, she has significantly contributed to the field through research, clinical practice, and education. Dr. Ruengkhachorn’s expertise spans minimally invasive surgery, integrative oncology, and advanced gynecologic cancer treatment protocols. Her scholarly activities have earned her recognition within the national and international medical community, where she continues to drive progress in women’s cancer care.

Profile

Orcid

Education

Dr. Ruengkhachorn has pursued a thorough and distinguished academic journey. She earned her Doctor of Medicine degree from the Faculty of Medicine Siriraj Hospital, Mahidol University, in 2000. She continued her postgraduate training at the same institution, completing graduate diplomas in Basic and Clinical Sciences in 2004 and 2005, respectively. She further specialized by earning a Thai Board certification in Obstetrics and Gynecology in 2006, and in Gynecologic Oncology from Chiangmai University in 2008. Her interest in surgical techniques led her to complete certifications in gynecologic laparoscopic surgery in 2012 and undergo visiting clinical training in minimally invasive surgery at Mayo Clinic, USA, the same year. In 2017, she added a Certificate of Advanced Medical Epidemiology from Thammasat University, equipping her with robust research design and analysis capabilities.

Experience

Dr. Ruengkhachorn began her academic career as an Instructor in 2009 at Siriraj Hospital, advancing to Assistant Professor in 2013 and later to Associate Professor in 2016. Over the years, she has played a central role in mentoring medical students and residents, particularly in gynecologic oncology rotations. Prior to her tenure at Siriraj Hospital, she also served as a tutor in the Gynecologic Oncology Department at Chiangmai University. Her long-standing service in one of Thailand’s leading tertiary care centers has enabled her to influence treatment protocols and participate in numerous multi-disciplinary teams that shape national cancer care standards.

Research Interest

Dr. Ruengkhachorn’s research interests are grounded in the clinical challenges of gynecologic oncology. She focuses on cervical and ovarian cancer management, outcomes of surgical interventions, and predictive biomarkers. Her work extends into evaluating oncologic outcomes, the role of pathology in treatment planning, and recently, integrating artificial intelligence and precision medicine approaches. She has also explored minimally invasive surgical techniques, HPV-related cytological abnormalities, and the role of traditional medicine in cancer care. Her aim is to translate clinical findings into practice guidelines that improve survival and quality of life for women affected by reproductive cancers.

Award

Her research has received multiple accolades that highlight both scientific rigor and relevance. In 2008, she won the GSK Research Award for her work on predicting the need for adjuvant radiotherapy in early-stage cervical cancer. The R2R Research Award followed in 2014, recognizing her investigation into atypical glandular cells in cytology. In 2017, she earned the “Research of the Month” title at Siriraj Hospital for her landmark study on outcomes of advanced cervical carcinoma treated with chemotherapy at a tertiary referral center. These honors underscore her contributions to evidence-based gynecologic oncology in high-incidence settings.

Publication

Dr. Ruengkhachorn has published extensively in peer-reviewed journals. Seven representative publications include:

  1. Ruengkhachorn I et al., “Oncologic outcomes of stage IVB or persistent or recurrent cervical carcinoma patients treated with chemotherapy,” Int J Gynecol Cancer, 2016, cited 49 times.

  2. Ittiamornlert P, Ruengkhachorn I, “Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes,” BMC Cancer, 2019, cited 61 times.

  3. Ruengkhachorn I et al., “Undiagnosed uterine sarcomas identified during surgery for presumed leiomyoma,” Int J Gynecol Cancer, 2017, cited 34 times.

  4. Ruengkhachorn I et al., “Comparison of oncologic outcomes of unanticipated cervical carcinoma,” Gynecol Oncol, 2019, cited 57 times.

  5. Phianpiset R, Ruengkhachorn I et al., “ASCCP risk-based colposcopy recommendations in Thai women,” Obstet Gynecol, 2020, cited 66 times.

  6. Ruengkhachorn I et al., “Predicting factors associated with resistance to Methotrexate in GTN,” Asian Pac J Clin Oncol, 2022, cited 23 times.

  7. Ruengkhachorn I et al., “High-risk HPV genotyping in atypical squamous cells,” Scientific Reports, 2023, cited 15 times.
    These publications reflect her diverse yet focused contributions in clinical oncology and diagnostic advancement.

Conclusion

Dr. Irene Ruengkhachorn has emerged as a leader in gynecologic oncology in Thailand through her relentless pursuit of clinical excellence, academic advancement, and translational research. Her academic path, enriched by international exposure and cross-disciplinary integration, positions her at the forefront of modern cancer care. As she continues to mentor young physicians, publish impactful research, and lead clinical innovation, Dr. Ruengkhachorn exemplifies the synergy of research and compassionate care in advancing women’s health. Her ongoing engagement with global research communities ensures her contributions remain both relevant and far-reaching in the evolving field of gynecologic oncology.

Hossein Nikzad | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Prof. Hossein Nikzad | AI in Healthcare | Best Researcher Award

Kashan University of Medical Sciences, Iran

Hossein Nikzad is a distinguished academic and researcher affiliated with the Kashan University of Medical Sciences in Kashan, Iran. He is a key figure in the Anatomical Science Research Center at the university, contributing significantly to research in areas such as male infertility, pharmacology, oxidative stress, and reproductive biology. His scientific work is marked by his expertise in understanding complex biological mechanisms and exploring potential therapeutic approaches to treat infertility and related disorders.

Profile

Google Scholar

Education

Dr. Hossein Nikzad earned his academic qualifications from reputable institutions, building a solid foundation in the fields of anatomy and reproductive health. Over the years, his educational journey has been intertwined with his commitment to advancing scientific research in reproductive medicine, with a specific focus on male infertility and related pathologies.

Experience

Dr. Nikzad’s professional experience spans multiple research and teaching roles, where he has been a key contributor to both academic and scientific communities. His work at Kashan University of Medical Sciences is complemented by collaborations with national and international researchers. His research focuses on reproductive medicine, particularly the effects of oxidative stress on male infertility, therapeutic interventions, and the molecular biology of various reproductive conditions. His experience extends into various research domains, including the use of herbal medicine in infertility treatment and the exploration of novel biological markers.

Research Interests

Dr. Nikzad’s primary research interests lie in the areas of oxidative stress, male infertility, and the molecular underpinnings of reproductive health. He is also interested in the therapeutic potential of antioxidants and other herbal remedies in treating infertility. His studies have delved into various related fields, such as the interaction between long noncoding RNAs and gynecological cancers, the effects of diet on reproductive health, and the development of therapeutic strategies to combat viral infections like COVID-19.

Awards

Dr. Nikzad has earned recognition for his outstanding contributions to the field of anatomical sciences and reproductive medicine. His work has been cited widely in numerous scientific journals, reflecting his influence and leadership in these research areas. While specific awards or nominations are not detailed, his research impact, including over 3000 citations, speaks to his global recognition as a leader in his field.

Publications

Barati E, Nikzad H, Karimian M. “Oxidative stress and male infertility: current knowledge of pathophysiology and role of antioxidant therapy in disease management,” Cellular and Molecular Life Sciences, 77, 93-113, 2020.

Hosseini ES, Kashani NR, Nikzad H, Azadbakht J, Bafrani HH, et al. “The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies,” Virology, 551, 1-9, 2020.

Hosseini ES, Meryet-Figuiere M, Sabzalipoor H, Kashani HH, Nikzad H, et al. “Dysregulated expression of long noncoding RNAs in gynecologic cancers,” Molecular Cancer, 16, 1-13, 2017.

Kabir-Salmani M, Nikzad H, Shiokawa S, Akimoto Y, Iwashita M. “Secretory role for human uterodomes (pinopods): secretion of LIF,” Molecular Human Reproduction, 11(8), 553-559, 2005.

Mohammadi F, Nikzad H, Taherian A, Amini Mahabadi J, Salehi M. “Effects of herbal medicine on male infertility,” Anatomical Sciences Journal, 10(4), 3-16, 2017.

Aghaei S, Nikzad H, Taghizadeh M, Tameh AA, Taherian A, Moravveji A. “Protective effect of Pumpkin seed extract on sperm characteristics, biochemical parameters, and epididymal histology in adult male rats treated with Cyclophosphamide,” Andrologia, 46(8), 927-935, 2014.

Mobasseri N, Babaei F, Karimian M, Nikzad H. “Androgen receptor (AR)-CAG trinucleotide repeat length and idiopathic male infertility: A case-control trial and a meta-analysis,” EXCLI Journal, 17, 1167-1174, 2018.

Conclusion

Dr. Hossein Nikzad is a renowned researcher whose work has profoundly impacted the fields of reproductive biology, male infertility, and related therapeutic interventions. His extensive publications and research collaborations highlight his commitment to advancing scientific understanding of infertility and related disorders. Through his research, he continues to contribute valuable insights into improving the quality of life for individuals facing reproductive health challenges.

Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Published on by AI Data Scientist

Prof. Dr. Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Pathologist MD, PhD | University of Bari Aldo Moro | Italy

Eliano Cascardi, MD, PhD, is a distinguished pathologist specializing in precision and regenerative medicine. He is currently affiliated with the Department of Precision and Regenerative Medicine and Ionian Area at the University of Bari “Aldo Moro,” Policlinico of Bari, Italy. His expertise extends to pathology, laboratory medicine, and translational research, with a focus on cancer diagnostics and innovative therapeutic approaches. Dr. Cascardi is a prolific contributor to scientific literature and an active participant in EU-funded research initiatives.

Profile

Scopus

Education

Dr. Cascardi has an impressive educational background. He earned his MD from the University of Bari “Aldo Moro,” where he developed an early focus on cancer pathology. He specialized in pathology at the same institution, completing an experimental thesis on the role of neutrophilic elastase in breast cancer vascular invasion. Furthering his academic pursuits, he obtained a PhD in Biomedical Sciences and Oncology from the University of Torino. Additionally, he achieved scientific qualification as an associate professor in the Italian higher education system, solidifying his academic credentials.

Experience

Dr. Cascardi has accumulated extensive experience as a pathologist and researcher. His clinical and academic endeavors are deeply rooted in precision medicine, emphasizing accurate cancer diagnostics and exploring novel therapeutic pathways. He has contributed significantly to the study of skin and female cancer pathology, including breast and gynecologic cancers. Beyond clinical practice, Dr. Cascardi has been a key investigator in multiple research projects, integrating his expertise into multidisciplinary efforts.

Research Interests

Dr. Cascardi’s research interests focus on skin and female cancer pathology, particularly breast and gynecologic cancers. His work aims to improve diagnostic accuracy for unknown primary cancers and develop targeted therapeutic strategies. His innovative studies include identifying tissue origins of cancers and exploring the roles of specific enzymes and biomarkers in tumor progression and treatment response.

Awards and Nominations

Dr. Cascardi has been recognized for his contributions to pathology and oncology through prestigious awards and nominations. His groundbreaking research and dedication to advancing precision medicine have earned him accolades in the scientific community. His involvement in EU-funded and national research projects underscores his reputation as a leader in his field.

Selected Publications

Dellino, M. et al. (2024). “Artificial Intelligence in Cervical Cancer Screening: Opportunities and Challenges.” AI, 5(4), 2984–3000. [Cited by 10 articles].

Cazzato, G., Cascardi, E., et al. (2024). “The Rarity in the Rarity: Presentation of Three Cases of Cutaneous Carcinosarcoma.” Dermatopathology, 11(3), 209. [Cited by 7 articles].

Cascardi, E., et al. (2024). “Oral–Gut–Estrobolome Axis May Exert a Selective Impact on Oral Cancer.” Journal of Dental Research. [Cited by 5 articles].

Forte, M., Cascardi, E., et al. (2024). “Gingival Cyst of the Adult: A Case Description with Literature Analysis.” Reports, 7(3), 51. [Cited by 2 articles].

Sallicandro, L., Cascardi, E., et al. (2024). “Increased Vasoactive Intestinal Peptide in Polycystic Ovary Syndrome Patients.” Frontiers in Endocrinology, 15. [Cited by 3 articles].

Dellino, M., Cascardi, E., et al. (2023). “The Strange Case of Twin Reversed Arterial Perfusion (TRAP) Sequence.” Diagnostics, 13, 3109. [Cited by 8 articles].

Cazzato, G., Cascardi, E., et al. (2023). “Cutaneous Metastasis from Internal Malignancies: The Revealing Role of the Skin.” Cancers, 15(17), 4351. [Cited by 6 articles].

Conclusion

Dr. Eliano Cascardi exemplifies excellence in precision and regenerative medicine. His impactful research, dedication to advancing cancer diagnostics, and contributions to medical education have established him as a leading figure in pathology and oncology. Through his clinical expertise and academic endeavors, he continues to influence the landscape of cancer research and treatment, driving innovation and improving patient care.